One key finding: Patients whose depression symptoms disappeared took higher than typical drug doses, and received close monitoring and frequent dose adjustments in the first three months – a level of care that few U.S. patients today receive.
The main goal of the government-funded study is to identify what harder-to-treat patients should try when initial treatment fails, instead of abandoning therapy in frustration. Those results are due in a few months.&rdquo (Optimum Online )
As anyone who has been reading FmH for any length of time knows, one of my pet peeves is the undertreatment of depressive disorders by the modern medical establishment, which then goes on to blame the antidepressants which have either been inadequately prescribed or inadequately supervised. The critical first months of treatment for acute depression require frequent physician visits and attention beyond the time or expertise of the primary care physicians who have been convinced by the antidepressant manufacturers that the condition is trivial and trouble-free to treat like any other primary care condition.